iRegene's NouvSight001 Receives Clinical Trial Clearance in the U.S. and China for Retinitis Pigmentosa #China #Chengdu #retinitis_pigmentosa #iRegene_Therapeutics #NouvSight001
@newsen.bsky.social@newsen.bsky.social
@newsen.bsky.socialiRegene's NouvSight001 Receives Clinical Trial Clearance in the U.S. and China for Retinitis Pigmentosa #China #Chengdu #retinitis_pigmentosa #iRegene_Therapeutics #NouvSight001